ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,178Medicare Part D Prescriptions Filled, Including Refills

Rank: 477 out of 2343

$583K Total Retail Price of All Prescriptions

Rank: 513 out of 2343

613 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
20% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

4% of this provider’s 613 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 9,262 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
LEVOTHYROXINE SODIUM 461 387 1 2
SIMVASTATIN 436 415 2 1
OMEPRAZOLE 393 350 3 4
ATENOLOL 306 295 4 12
LISINOPRIL 295 278 5 3
ATORVASTATIN CALCIUM 270 259 6 10
AMLODIPINE BESYLATE 257 252 7 5
METOPROLOL TARTRATE 240 231 8 7
FUROSEMIDE 236 227 9 6
HYDROCHLOROTHIAZIDE 219 191 10 11
METFORMIN HCL 199 187 11 9
SERTRALINE HCL 176 153 12 20
WARFARIN SODIUM 169 156 13 8
MELOXICAM 147 137 14 68
SPIRONOLACTONE 131 131 15 65
CLOPIDOGREL 106 105 16 26
DONEPEZIL HCL 105 92 17 21
POTASSIUM CHLORIDE 104 104 18 18
CITALOPRAM HBR 103 85 19 17
LOSARTAN POTASSIUM 97 97 20 19
DILTIAZEM 24HR ER 87 87 21 76
GLIPIZIDE 86 86 22 56
ISOSORBIDE MONONITRATE ER 86 84 22 32
ALLOPURINOL 84 84 24 31
PRAVASTATIN SODIUM 83 72 25 15
PLAVIX 83 83 25 38
ALENDRONATE SODIUM 80 78 27 28
SYNTHROID 77 77 28 40
TRIAMTERENE-HCTZ 77 72 28 57
FELODIPINE ER 76 73 30 116
QUINAPRIL HCL 74 66 31 73
LANSOPRAZOLE 72 65 32 162
FLUTICASONE PROPIONATE 71 59 33 46
DIGOXIN 67 67 34 35
CARVEDILOL 66 66 35 27
PAROXETINE HCL 66 39 35 66
TRAMADOL HCL 66 59 35 25
LISINOPRIL-HYDROCHLOROTHIAZIDE 65 62 38 42
DOXAZOSIN MESYLATE 64 42 39 98
LOVASTATIN 63 54 40 47
TAMSULOSIN HCL 61 60 41 29
HYDROCODONE-ACETAMINOPHEN 60 50 S3 42 13
FINASTERIDE 57 57 43 80
ENALAPRIL MALEATE 57 57 43 58
PANTOPRAZOLE SODIUM 56 56 45 22
ADVAIR DISKUS 55 55 46 34
NEXIUM 54 45 47 33
DIOVAN 52 51 48 23
TRAZODONE HCL 50 42 49 53
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.